tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market
Want to see CNSP full AI Analyst Report?

CNS Pharmaceuticals (CNSP) Ownership - Who Owns CNS Pharmaceuticals?

1,098 Followers

CNS Pharmaceuticals (CNSP) Ownership Overview

26.02%0.47%<0.01%0.48%73.02%
26.02% Insiders
<0.01% Other Institutional Investors
0.48% ETFs
73.02% Public Companies and
Individual Investors
The ownership structure of CNS Pharmaceuticals (CNSP) stock is a mix of institutional, retail, and individual investors. Approximately 0.95% of the company’s stock is owned by Institutional Investors, 26.02% is owned by Insiders, and 73.02% is owned by Public Companies and Individual Investors.
The ownership structure of CNS Pharmaceuticals (CNSP) stock is a mix of institutional, retail, and individual investors. Approximately 0.47% of the company’s stock is owned by Institutional Investors, 26.02% is owned by Insiders, and 0.48% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 18, 2026
xxxxxxxxxxxxx
$10000
May 20, 2026
xxxxxxxxxxxxx
$33938

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
215,676Insider14.76%1,235,823
103,438Insider7.08%592,700
43,006Insider2.94%246,424
11,100Insider0.76%63,603
7,100Insider0.49%40,683
6,993Institution0.48%40,070
6,921Institution0.47%39,657
4,750Insider0.33%27,218
2,000Insider0.14%11,460

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,921Institution0.47%39,657

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,993Institution0.48%40,000

FAQ

Who Owns CNS Pharmaceuticals (CNSP)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 26.02% is held by insiders, and 73.02% is held by retail investors.
    What percentage of CNS Pharmaceuticals (CNSP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of CNS Pharmaceuticals (CNSP) stock is held by institutional investors.
      What percentage of CNS Pharmaceuticals (CNSP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 73.02% of CNS Pharmaceuticals (CNSP) stock is held by retail investors.
        Who owns the most shares of CNS Pharmaceuticals (CNSP)?
        John Climaco owns the most shares of CNS Pharmaceuticals (CNSP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.